Adding NTS to NSCLC cells significantly increases phosphotyrosine1068-EGFR and phosphotyrosine1248-HER2 and ROS by 355, 285, and 228%, respectively. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.